Kim, N.; Kim, K.; Jeong, S.; Kim, J.; Cho, H.; Lee, Y.-J.; Park, S.
Development and Evaluation of Bilayer Sustained-Release Tablets of Ruxolitinib Using Discriminative Pharmacokinetic Analysis and IVIVC. Pharmaceutics 2025, 17, 432.
https://doi.org/10.3390/pharmaceutics17040432
AMA Style
Kim N, Kim K, Jeong S, Kim J, Cho H, Lee Y-J, Park S.
Development and Evaluation of Bilayer Sustained-Release Tablets of Ruxolitinib Using Discriminative Pharmacokinetic Analysis and IVIVC. Pharmaceutics. 2025; 17(4):432.
https://doi.org/10.3390/pharmaceutics17040432
Chicago/Turabian Style
Kim, Namhyuck, Kyoungho Kim, Seungwei Jeong, Jiyeong Kim, Helen Cho, Young-Joo Lee, and Sangyeob Park.
2025. "Development and Evaluation of Bilayer Sustained-Release Tablets of Ruxolitinib Using Discriminative Pharmacokinetic Analysis and IVIVC" Pharmaceutics 17, no. 4: 432.
https://doi.org/10.3390/pharmaceutics17040432
APA Style
Kim, N., Kim, K., Jeong, S., Kim, J., Cho, H., Lee, Y.-J., & Park, S.
(2025). Development and Evaluation of Bilayer Sustained-Release Tablets of Ruxolitinib Using Discriminative Pharmacokinetic Analysis and IVIVC. Pharmaceutics, 17(4), 432.
https://doi.org/10.3390/pharmaceutics17040432
